Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710151 · ClinicalTrials.gov registry record
Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 80
- Enrollment target
NCT00710151 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 80 participants.
The verdict
NCT00710151 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This research is being done to investigate cognition in long term survivors of Primary Central Nervous System Lymphoma (PCNSL). Sometimes caregivers as well as patients who no longer have the disease report cognitive problems such as reduced memory or attentional dysfunction and decreased quality of life. Unfortunately, little is known about what may contribute to this cognitive dysfunction in part because PCNSL is a rare disease and sensitive tests have not often been used in the research studies. This project is being conducted to help understand what factors, such as radiation, may contribute to cognitive dysfunction and better define the relationship between brain structure and thinking in people who have had PCNSL.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00710151
The ClinicalTrials.gov registry entry for NCT00710151 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00710151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00710151 about?
NCT00710151 is a clinical study titled "Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors". This research is being done to investigate cognition in long term survivors of Primary Central Nervous System Lymphoma (PCNSL). Sometimes caregivers as well as patients who no longer have the disease report cognitive problems such as reduced memory or attentional dysfunction and decreased quality of...
What is the current status of trial NCT00710151?
This trial is currently terminated. The enrollment target is 80 participants. The study started on 2008-07. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00710151?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.